HYPR
Price
$0.66
Change
-$0.03 (-4.35%)
Updated
Apr 4 closing price
Capitalization
70.76M
33 days until earnings call
RSLS
Price
$0.46
Change
+$0.08 (+21.05%)
Updated
Apr 4 closing price
Capitalization
4.33M
Ad is loading...

HYPR vs RSLS

Header iconHYPR vs RSLS Comparison
Open Charts HYPR vs RSLSBanner chart's image
Hyperfine
Price$0.66
Change-$0.03 (-4.35%)
Volume$451.93K
Capitalization70.76M
ReShape Lifesciences
Price$0.46
Change+$0.08 (+21.05%)
Volume$122.67M
Capitalization4.33M
HYPR vs RSLS Comparison Chart
Loading...
HYPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPR vs. RSLS commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPR is a StrongBuy and RSLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (HYPR: $0.66 vs. RSLS: $0.46)
Brand notoriety: HYPR and RSLS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HYPR: 30% vs. RSLS: 1094%
Market capitalization -- HYPR: $70.76M vs. RSLS: $4.33M
HYPR [@Medical Specialties] is valued at $70.76M. RSLS’s [@Medical Specialties] market capitalization is $4.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPR’s FA Score shows that 1 FA rating(s) are green whileRSLS’s FA Score has 1 green FA rating(s).

  • HYPR’s FA Score: 1 green, 4 red.
  • RSLS’s FA Score: 1 green, 4 red.
According to our system of comparison, both HYPR and RSLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPR’s TA Score shows that 2 TA indicator(s) are bullish while RSLS’s TA Score has 1 bullish TA indicator(s).

  • HYPR’s TA Score: 2 bullish, 7 bearish.
  • RSLS’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, RSLS is a better buy in the short-term than HYPR.

Price Growth

HYPR (@Medical Specialties) experienced а -8.32% price change this week, while RSLS (@Medical Specialties) price change was +18.89% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.38%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

HYPR is expected to report earnings on May 08, 2025.

RSLS is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Medical Specialties (-6.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPR($70.8M) has a higher market cap than RSLS($4.33M). HYPR YTD gains are higher at: -24.989 vs. RSLS (-89.686). RSLS has higher annual earnings (EBITDA): -36.72M vs. HYPR (-47.06M). HYPR has more cash in the bank: 75.2M vs. RSLS (1.45M). HYPR has less debt than RSLS: HYPR (185K) vs RSLS (285K). HYPR has higher revenues than RSLS: HYPR (11M) vs RSLS (9.81M).
HYPRRSLSHYPR / RSLS
Capitalization70.8M4.33M1,637%
EBITDA-47.06M-36.72M128%
Gain YTD-24.989-89.68628%
P/E RatioN/AN/A-
Revenue11M9.81M112%
Total Cash75.2M1.45M5,190%
Total Debt185K285K65%
FUNDAMENTALS RATINGS
RSLS: Fundamental Ratings
RSLS
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HYPRRSLS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
HYPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTVE18.01N/A
N/A
Pactiv Evergreen
UVSP25.99-0.45
-1.70%
Univest Financial Corp
SMX1.56-0.13
-7.69%
SMX (Security Matters) Public Limited Company
KNSL459.11-39.49
-7.92%
Kinsale Capital Group
CRGO1.94-0.18
-8.49%
Freightos Limited

HYPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPR has been loosely correlated with SGHT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPR jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPR
1D Price
Change %
HYPR100%
-4.44%
SGHT - HYPR
33%
Loosely correlated
+3.14%
ICAD - HYPR
29%
Poorly correlated
-5.41%
RSLS - HYPR
29%
Poorly correlated
+2.22%
TMCI - HYPR
28%
Poorly correlated
-1.02%
RBOT - HYPR
25%
Poorly correlated
-7.48%
More

RSLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RSLS has been loosely correlated with BIAF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RSLS jumps, then BIAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSLS
1D Price
Change %
RSLS100%
+2.22%
BIAF - RSLS
56%
Loosely correlated
-2.52%
HSCS - RSLS
35%
Loosely correlated
-5.96%
GMED - RSLS
31%
Poorly correlated
-4.43%
AZTA - RSLS
30%
Poorly correlated
-6.96%
LFWD - RSLS
29%
Poorly correlated
-8.13%
More